Correlation Between Novo Nordisk and Arcellx

Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Arcellx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Arcellx into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Novo Nordisk AS and Arcellx, you can compare the effects of market volatilities on Novo Nordisk and Arcellx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Arcellx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Arcellx.

Diversification Opportunities for Novo Nordisk and Arcellx

0.33

Correlation Coefficient

Novo Nordisk  Arcellx

Weak diversification

The 3 months correlation between Novo and Arcellx is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Arcellx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcellx and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Arcellx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcellx has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Arcellx go up and down completely randomly.

Pair Corralation between Novo Nordisk and Arcellx

Assuming the 90 days horizon Novo Nordisk is expected to generate 2.71 times less return on investment than Arcellx. But when comparing it to its historical volatility, Novo Nordisk AS is 1.34 times less risky than Arcellx. It trades about 0.03 of its potential returns per unit of risk. Arcellx is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  3,144  in Arcellx on October 9, 2024 and sell it today you would earn a total of  4,357  from holding Arcellx or generate 138.58% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Novo Nordisk AS  vs.  Arcellx

Novo Nordisk AS

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Arcellx

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Arcellx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's essential indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Novo Nordisk and Arcellx

The main advantage of trading using opposite Novo Nordisk and Arcellx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Arcellx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcellx will offset losses from the drop in Arcellx's long position.

The idea behind Novo Nordisk AS and Arcellx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.